A new view on congenital heart disease: Clinical burden prevision of changing patients

Journal of Cardiovascular Medicine

Volumn 12, Issue 7, 2011, Pages 487-492

  Daliento, Luciano ^a   Cecchetto, Antonella ^a   Bagato, Francesco ^a   Dal Bianco, Lucia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

congenital heart disease; epidemiology; grown up congenital heart community

Indexed keywords

ANEUPLOIDY; AORTA COARCTATION; CAUCASIAN; CONGENITAL HEART DISEASE; CONSANGUINITY; CULTURAL ANTHROPOLOGY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; ETHNICITY; FALLOT TETRALOGY; GENETIC COUNSELING; GENETIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; GREAT VESSELS TRANSPOSITION; HEALTH CARE COST; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; ITALY; LIVE BIRTH; MATERNAL AGE; MITRAL VALVE PROLAPSE; MONOSOMY X; MORBIDITY; MORTALITY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRESSURE GRADIENT; PREVALENCE; REPRODUCTIVE HISTORY; REVIEW; SOCIOECONOMICS; SURVIVAL; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; CARDIOLOGY; CLINICAL COMPETENCE; CONTINUITY OF PATIENT CARE; HEART DEFECTS, CONGENITAL; HUMANS; PREVALENCE; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958764108     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834743cf     Document Type: Review

References (60)

1. Mitchell SC, Korones SB, Berendes HW. CHD in 56109 births. Incidence and natural history. Circulation 1971; 43:323-332.
2. Hofman N, Tan HL, van Langen A, Wilde AM. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010; 55:2570-2576.
3. Roberts WC. The congenitally bicuspid aortic valve: a study of 85 autopsy cases. Am J Cardiol 1970; 26:72.
4. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 2010; 55:2789-2800.
5. Warth DC, King ME, Cohen JM, Tesoriero VL, Marcus E, Weyman AE. Prevalence of mitral valve prolapse in normal children. J Am Coll Cardiol 1985; 5:1173-1177. (Pubitemid 15051005)
6. Chatterjee T, Ritz A, Rehders TC, et al. Percutaneous transcatheter closure of patent foramen ovale. Minerva Cardioangiol 2006; 54:31-39. (Pubitemid 43343111)
7. Yener N, Oktar GL, Erer D, Yardimci MM, Yener A. Bicuspid aortic valve. Ann Thorac Cardiovasc Surg 2002; 8:264-267.
8. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 1999; 82:19-22. (Pubitemid 29309229)
9. Hoffman J, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890-1900. (Pubitemid 34628268)
10. Ferencz C, Correa-Villasenor A. Epidemiology of cardiovascular malformations: the state of the art. Cardiol Young 1991; 1:264-284.
11. Fixler DE, Pastor P, Chamberlin M, Sigman E, Eifler CW. Trends in congenital heart disease in Dallas County births, 1971-1984. Circulation 1990; 81:137-142. (Pubitemid 20031777)
12. Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000; 83:414-419. (Pubitemid 30316755)
13. Fyler DC. Report of the New England Regional Infant Cardiac Program. Pediatrics 1980; 65 (Suppl):375-461. (Pubitemid 10054488)
14. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at live birth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121:31-36. (Pubitemid 15150685)
15. Moller JH, Moodie DS, Blees M, Norton JB, Nouri S. Symptomatic heart disease in infants: comparison of three studies performed during 1969- 1987. Pediatr Cardiol 1995; 16:216-222.
16. Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001; 107:E32.
17. Bosi G, Garani G, Scorrano M, Calzolari E, IMER Working Party. Temporal variability in birth prevalence of congenital heart defects as recorded by a general birth defects registry. J Pediatr (Rio J) 2003; 142:690-698. (Pubitemid 36737174)
18. Pexieder T, Block D, EUROCAT WorkingGroup Party on CHD. EUROCAT subproject on epidemiology of CHD: first analysis of the completed study. In: Clark FB, Markwald RR, Takao A, editors. Development mechanisms of heart disease. Armonk, New York: Futura Publishing Co.; 1995. pp. 655- 678.
19. Samanek M, Slavi Z, Zborilova B, Hrobonova V, Voriskova M, Skovranek J. Prevalence, treatment and outcome of heart disease in live-born children: a prospective analysis of 91823 live-born children. Pediatr Cardiol 1989; 10:205-211. (Pubitemid 20052375)
20. Stoll C, Alembik A, Roth MP, De Greeter B. Risk factors in CHD. Eur J Epidemiol 1989; 5:382-391.
21. Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of cardiovascular defects. Part 2: A study based on data from three large registries of congenital malformations. Pediatr Cardiol 2003; 24:222-235. (Pubitemid 36920007)
22. Tennstedt C, Chaoui R, Körner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999; 82:34-39. (Pubitemid 29309233)
23. Paladini D, Russo MG, Teodoro A, et al. Prenatal diagnosis of congenital heart disease in the Naples area during the years 1994-1999: the experience of a joint fetal-pediatric cardiology unit. Prenat Diagn 2002; 22:532-545.
24. Clementi M, Stoll C. The EUROSCAN study. Ultrasound Obstet Gynecol 2001; 17:386-439.
25. Stoll C, Alembik Y, Dott B, et al. Evaluation of prenatal diagnosis of congenital heart disease. Prenat Diagn 1998; 18:801-807. (Pubitemid 28379392)
26. van der Pal-de Bruin KM, Graafmans W, Biermans MC, et al. The influence of prenatal screening and termination of pregnancy on perinatal mortality rates. Prenat Diagn 2002; 22:966-972. (Pubitemid 35407826)
27. Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 2005; 25:6-11. (Pubitemid 40128896)
28. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for adults with CHD. J Am Coll Cardiol 2008; 23:e143-e263.
29. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46:1-8. (Pubitemid 40905121)
30. Niwa K, Perloff JK, Webb GD, et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol 2004; 96:211-216. (Pubitemid 38979900)
31. Perloff JK. Pediatric congenital cardiac becomes a postoperative adult. The changing population of congenital heart disease. Circulation 1973; 47:606-619.
32. Reid GJ, Irvine MJ, McCrindle BW, et al. Prevalence and correlates of successful transfer from paediatric to adult healthcare among a cohort of young adults with complex CHD. Pediatrics 2004; 113:197-205.
33. Perloff JK, Warnes CA. Challenges posed by adults with repaired congenital heart disease. Circulation 2001; 103:2637-2643. (Pubitemid 32521977)
34. American College of Cardiology. Care of the adult with congenital heart disease. Presented at the 32nd Bethesda Conference, Bethesda, Maryland, 2-3 October 2000. J Am Coll Cardiol 2001; 37:1161-1198.
35. Warnes CA, Liberthson R, Danielson GK, et al. Task Force 1: the changing profile of CHD in adult life. J Am Coll Cardiol 2001; 37:1170-1175.
36. British Cardiac Society. Report of the British Cardiac Society Working Party. Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart 2002; 88 (Suppl 1):i1-i14.
37. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115:163-172. (Pubitemid 46105714)
38. European Society of Cardiology Task Force. Management of grown up congenital heart disease. Eur Heart J 2003; 24:1035-1084.
39. Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect. N Engl J Med 1995; 333:469-473.
40. Petit J. Interatrial communications: problems due to adult age [in French]. Arch Mal Coeur 2002; 95:1069-1073.
41. Gatzoulis MA, Freeman MA, Siu SC, Webb G, Harris L. Atrial arrhythmias after surgical closure of atrial septal defects in adults. N Engl J Med 1999; 340:839-846. (Pubitemid 29142627)
42. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Caldero'n J. Surgical treatment for secundum atrial septal defects 40 years old. A randomized clinical trial. J Am Coll Cardiol 2001; 38:2035-2042. (Pubitemid 33120933)
43. Gabriel HM, Heger M, Innerhofer P, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol 2002; 39:1066-1071. (Pubitemid 34234132)
44. Moller JH, Patton C, Varco RL, Lillehei CW. Late results (30-35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol 1991; 68:1491-1497.
45. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of CHD. Results of treatment of patients with ventricular septal defects. Circulation 1993; 87:138-151.
46. Daliento L, Somerville J, Patrizia P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19:1845-1855. (Pubitemid 28556655)
47. Daliento L. Total correction of tetralogy of Fallot: late clinical follow-up. Ital Heart J 2002; 3:24-27. (Pubitemid 34269549)
48. Daliento L, Rizzoli G, Menti L, et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart 1999; 81:650-655. (Pubitemid 29260193)
49. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32:245-251. (Pubitemid 28351069)
50. Padalino MA, Stellin G, Brawn WJ, et al. Arterial switch operation after left ventricular retraining in adult. Ann Thorac Surg 2000; 70:1753-1757.
51. Diller GP, Giardini A, Dimopoulos K, et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010; 31:3073-3083.
52. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol 2007; 28:448-456. (Pubitemid 350160289)
53. Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001; 85:710-715.
54. Meyer AA, Joharchi MS, Kundt G, et al. Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation. Eur Heart J 2005; 26:617-622. (Pubitemid 40461104)
55. Duffiels MG, Mulder KM, Trip MD, et al. Atherosclerosis in patients with cyanotic congenital heart disease. Circ J 2010; 74:1436-1441.
56. Daliento L, Mazzotti E, Mongillo E, Rotundo M, Dalla Volta S. Life expectancy and quality of life in adult patients with congenital heart disease. Ital Heart J 2002; 3:339-347. (Pubitemid 34823289)
57. Daliento L, Mapelli D, Volpe B. Measurement of cognitive outcome and quality of life in congenital heart disease. Heart 2006; 92:569-574.
58. Scarso P, Volpe B, Melendugno A, Daliento L. Psychological problems and cognitive impairments in the GUCH Community. Ital Heart J Suppl 2003; 4:705-711.
59. Picchio FM, Colonna PL, Daliento L, et al. Criteria for work capacity evaluation, adequacy for specific attitudes towards physical activity and sports, and insurance eligibility in subjects with congenital cardiopathy. Ital Heart J Suppl 2001; 2:46-77.
60. Chessa M, Arciprete P, Bossone E, et al. A multicentre approach for the management of adults with congenital heart disease. J Cardiovasc Med (Hagerstown) 2006; 7:701-705. (Pubitemid 44319077)